Merz Pharmaceuticals Receives J-Code For Xeomin® (incobotulinumtoxinA)
GREENSBORO, N.C., Jan. 4, 2012 /PRNewswire/ -- Merz Pharmaceuticals, LLC, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a product-specific Healthcare Common Procedure Coding System (HCPCS) billing code, J0588 "INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT" for Xeomin® (incobotulinumtoxinA), effective beginning January 1, 2012. The U.S.

"New 4 Weeks To Good Balance Program" Introduced For Seniors And Others Afraid Of Falling.
Falls have become a leading cause of death, especially amongst seniors. Falls are also a leading cause of nonfatal injuries in all age groups, not just seniors. Risk of fall is clinically measurable, and it is detectable long before you physically realize that there is a problem. So, if you perceive that your balance is bad, the problem has already become severe.

Novel Techniques Offers New Freedom to Patients with Parkinson's Disease, Epilepsy, Dystonia, and Tremor
Dr. Brian Snyder, a neurosurgeon at Neurological Surgery PC of Long Island, NY, describes how state-of-the-art treatments in which he is specially trained can help relieve some of the symptoms caused by neurological diseases. Neurological Surgery, P.C. is a practice composed of some of the most highly trained doctors in the New York area. Aside from neurological and spine treatments, the practice also offers MRI testing, pain management, neuro-oncology and physical therapy.

Abnormal Brain Circuits May Prevent Movement Disorder
Most people who carry a genetic mutation for a movement disorder called dystonia will never develop symptoms, a phenomenon that has puzzled scientists since the first genetic mutation was identified in the 1990s. Now, scientists at The Feinstein Institute for Medical Research () have figured out why these mutation carriers are protected from symptoms of the disorder - they have an additional lesion that evens the score.